NDC 61703-350

Methotrexate

Methotrexate

Methotrexate is a Intra-arterial; Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Methotrexate Sodium.

Product ID61703-350_0c1d5f83-0fca-4986-9e06-127b1319c980
NDC61703-350
Product TypeHuman Prescription Drug
Proprietary NameMethotrexate
Generic NameMethotrexate
Dosage FormInjection, Solution
Route of AdministrationINTRA-ARTERIAL; INTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2014-09-25
Marketing CategoryNDA / NDA
Application NumberNDA011719
Labeler NameHospira, Inc.
Substance NameMETHOTREXATE SODIUM
Active Ingredient Strength25 mg/mL
Pharm ClassesFolate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 61703-350-10

5 VIAL, MULTI-DOSE in 1 CARTON (61703-350-10) > 2 mL in 1 VIAL, MULTI-DOSE (61703-350-09)
Marketing Start Date2014-09-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 61703-350-10 [61703035010]

Methotrexate INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA011719
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-09-25

NDC 61703-350-09 [61703035009]

Methotrexate INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA011719
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-09-25

NDC 61703-350-37 [61703035037]

Methotrexate INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA011719
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-07-27

NDC 61703-350-38 [61703035038]

Methotrexate INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA011719
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2004-12-15

Drug Details

Active Ingredients

IngredientStrength
METHOTREXATE SODIUM25 mg/mL

OpenFDA Data

SPL SET ID:0e30eaef-5a09-4104-8a11-c32933eadeab
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1946772
  • Pharmacological Class

    • Folate Analog Metabolic Inhibitor [EPC]
    • Folic Acid Metabolism Inhibitors [MoA]

    Medicade Reported Pricing

    61703035038 METHOTREXATE 50 MG/2 ML VIAL

    Pricing Unit: ML | Drug Type:

    NDC Crossover Matching brand name "Methotrexate" or generic name "Methotrexate"

    NDCBrand NameGeneric Name
    0143-9367MethotrexateMethotrexate
    0143-9516MethotrexateMethotrexate
    0143-9517MethotrexateMethotrexate
    0143-9518MethotrexateMethotrexate
    0143-9519MethotrexateMethotrexate
    0143-9830MethotrexateMethotrexate
    0378-0014Methotrexatemethotrexate
    0555-0572MethotrexateMethotrexate
    0703-3671MethotrexateMethotrexate
    0703-3675MethotrexateMethotrexate
    0703-3678MethotrexateMethotrexate
    68382-775MethotrexateMethotrexate
    69238-1423MethotrexateMethotrexate
    70518-0223METHOTREXATEMETHOTREXATE
    70518-1251MethotrexateMethotrexate
    70518-1398MethotrexateMethotrexate
    70771-1058MethotrexateMethotrexate
    71335-0782MethotrexateMethotrexate
    16729-277MethotrexateMethotrexate
    21695-111MethotrexateMethotrexate
    42291-594MethotrexateMethotrexate
    42254-110METHOTREXATEMETHOTREXATE
    43063-439MethotrexateMethotrexate
    47335-235MethotrexateMethotrexate
    50090-0294METHOTREXATEMETHOTREXATE
    50090-2345MethotrexateMethotrexate
    50090-3418MethotrexateMethotrexate
    51079-670MethotrexateMethotrexate
    51407-121MethotrexateMethotrexate
    61703-350MethotrexateMethotrexate
    61703-408MethotrexateMethotrexate
    63323-122MethotrexateMethotrexate
    63323-123MethotrexateMethotrexate
    66336-338METHOTREXATEMETHOTREXATE
    67253-320METHOTREXATEMETHOTREXATE
    67457-480MethotrexateMethotrexate
    67457-466MethotrexateMethotrexate
    71335-1118MethotrexateMethotrexate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.